Association between the systemic immune-inflammation index and the outcome of liver fibrosis in patients with chronic hepatitis C
Our findings suggested that the SII was positively associated with non-improved outcomes of liver fibrosis in patients with CHC. These results need to be validated in large-scale prospective cohorts.
Authors
- Jiayi Wang (ORCID: https://orcid.org/0000-0003-1688-2864)
- Hong Tang (ORCID: https://orcid.org/0000-0003-3912-2067)
- Yuanji Ma (ORCID: https://orcid.org/0000-0002-1025-6080)
- Lingyao Du (ORCID: https://orcid.org/0000-0002-2688-4604)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-11-26
- DOI
- https://doi.org/10.3389/fmed.2024.1486503
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- National Key Research and Development Program of China